GlassScriptPhysician profile
Kelly A Brister
NPI 1811381957
$7,442.36
in general payments reported to CMS, 2019-2025
16 companies · $2,134 in 2025
The $2,134 reported for 2025 was more than what 82% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $125 · 2021: $237 · 2022: $743 · 2023: $1,430 · 2024: $2,571 · 2025: $2,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,580 · Food and Beverage: $2,546 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,580.38 |
| Food and Beverage | $2,546.17 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,112.20 | 2022-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $773.23 | 2021-2025 | Tisseel, Perclot, Artiss |
| Medtronic, INC. | $489.83 | 2021-2025 | Signia |
| Conmed Corporation | $264.75 | 2023-2025 | Airseal |
| Boston Scientific Corporation | $221.07 | 2019-2020 | |
| Dilon Technologies, INC. | $142.12 | 2024 | Hemoblast Bellows |
| Innovation Technologies INC | $136.12 | 2025 | Irrisept |
| Shire North American Group INC | $105.79 | 2019 | |
| Zimmer Biomet Holdings, INC. | $43.25 | 2025 | Ribfix Blu Advantage |
| Abbvie INC. | $31.05 | 2025 | |
| Davol INC. | $31.04 | 2023 | Arista Ah Flexitip |
| Somavac Medical Solutions, INC. | $25.98 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.01 | 2024 | Gattex |
| Solventum Corporation | $15.78 | 2024 | Prevena |
| Ethicon US, LLC | $15.26 | 2024 | Echelon; Endopath |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13.88 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Brister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.